Research on Lung Disease Related to Rheumatoid Arthritis
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Recruiting
Observational Study
Rheumatoid Arthritis
Interstitial Lung Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 450 (estimated)
- Sponsor
- University of Colorado, Denver · Other
Who this trial is looking for
This trial is looking for people with Rheumatoid Arthritis who have lung disease. Participants will help researchers understand how the disease progresses by providing information about their condition.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years old or older
- I have been diagnosed with Rheumatoid Arthritis-related lung disease
You may not be able to join if
- I have received treatment specifically for my lung disease
- I cannot give informed consent
- I am pregnant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression.
The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic feature…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria
* 18 years of age or older
Exclusion Criteria:
* Prior medication treatment specifically for RA-ILD
* Inability to give informed consent
* Pregnant women
Contacts